Tuesday, September 30, 2025 9/30/2025

Addressing negative social experiences through coping and resilience to reduce methamphetamine use and improve PrEP cascade progression among Latino MSM

Award Number: K01DA055521
ORGANIZATION: NATIONAL INSTITUTE ON DRUG ABUSE
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: TRAINING/TRAINEESHIP
PERIOD OF PERFORMANCE START DATE: 09/01/2022
PERIOD OF PERFORMANCE END DATE: 08/31/2027

Group Awards By:

View Award Description

Addressing negative social experiences through coping and resilience to reduce methamphetamine use and improve PrEP cascade progression among Latino MSM - Negative social experiences are a main driver of HIV disparities among Latino men who have sex with men (LMSM), negatively affecting non-injection substance use (e.g. methamphetamine) and PrEP uptake. Addressing factors that influence PrEP cascade progression, such as negative social experiences and methamphetamine use, are essential to ending the HIV epidemic. Negative social experiences can occur across various sources (i.e. family, friends, others), mechanisms (i.e. anticipated, enacted), and types, which compound to produce and exacerbate deleterious health outcomes among LMSM. Social network analysis techniques can be leveraged to examine how LMSM interact with and are affected by network members and inform targets for meaningful interventions focused on network members that (1) provoke negative social experiences and (2) provide social support. This K01 will provide the candidate, Dr. Algarin, with skills to conduct complex longitudinal multi-level structural equation modeling to examine the direct and indirect effects between negative social experiences and methamphetamine use risk and PrEP cascade progression through coping and resilience (AIM 1) and how sources of negative social experiences moderate these pathways (AIM 2) leveraging data from 500 LMSM enrolled in the NEXUS study (R01MH123282; PI: Smith). Using a community-engaged approach, Dr. Algarin will draw from these analyses to adapt a multi-level intervention to address negative social experiences through coping and resilience to decrease methamphetamine use risk and improve PrEP cascade progression (AIM 3). As an emerging scholar, Dr. Algarin will leverage the UCSD training infrastructure to build his professional independence and skills to promote HIV prevention interventions, positioning him as the next generation of scholars to end the HIV epidemic in the US. Specifically, Dr. Algarin seeks training to advance his statistical capacities (T1), gain proficiency multi-level intervention theories and concepts (T2) and multi-level intervention development and adaptation (T3), gain additional training in the ethical conduct of research (T4), and build skills for his professional development (T5). This K01 will provide Dr. Algarin with the necessary training and data to forge his research independence and produce a competitive future R34 to test the community- engaged, multi-level intervention he adapts as part of this study.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2025 ( Subtotal = $188,536 )
2025	2025	ARIZONA STATE UNIVERSITY	660 S MILL AVENUE STE 204	TEMPE	AZ	85281	MARICOPA	USA	Drug Use and Addiction Research Programs	000	4	9/3/2025	NON-COMPETING CONTINUATION	$188,536
														Subtotal = $188,536

Issue Date FY: 2024 ( Subtotal = $188,536 )
2024	2024	ARIZONA STATE UNIVERSITY	660 S MILL AVENUE STE 204	TEMPE	AZ	85281	MARICOPA	USA	Drug Use and Addiction Research Programs	000	3	8/22/2024	NON-COMPETING CONTINUATION	$188,536
														Subtotal = $188,536

Issue Date FY: 2023 ( Subtotal = $188,536 )
2023	2023	ARIZONA STATE UNIVERSITY	660 S MILL AVENUE STE 204	TEMPE	AZ	85281	MARICOPA	USA	Drug Use and Addiction Research Programs	001	2	8/11/2023	NON-COMPETING CONTINUATION	$188,536
2023	2022	ARIZONA STATE UNIVERSITY	660 S MILL AVE STE 312	TEMPE	AZ	85281	MARICOPA	USA	Drug Use and Addiction Research Programs	000	1	3/31/2023	NEW	$0
														Subtotal = $188,536

Issue Date FY: 2022 ( Subtotal = $188,536 )
2022	2022	ARIZONA STATE UNIVERSITY	660 S MILL AVE STE 312	TEMPE	AZ	85281	MARICOPA	USA	Drug Use and Addiction Research Programs	000	1	8/31/2022	NEW	$188,536
														Subtotal = $188,536

Grand Total All Awards = $754,144

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Addressing negative social experiences through coping and resilience to reduce methamphetamine use and improve PrEP cascade progression among Latino MSM

Award Number: K01DA055521

ORGANIZATION: NATIONAL INSTITUTE ON DRUG ABUSE

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: TRAINING/TRAINEESHIP

PERIOD OF PERFORMANCE START DATE: 09/01/2022

PERIOD OF PERFORMANCE END DATE: 08/31/2027

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer